Network Pharmacology‐Based Analysis of the Pharmacological Mechanisms of Aloperine on Cardiovascular Disease
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2020 (1) , 5180716
Abstract
Background. Aloperine is an active component of Sophora alopecuroides Linn, which has been extensively applied for the treatment of cardiovascular disease (CVD). However, our current understanding of the molecular mechanisms supporting the effects of aloperine on CVD remains unclear. Methods. Systematic network pharmacology was conducted to provide testable hypotheses about pharmacological mechanisms of the protective effects of aloperine against CVD. Detailed structure was obtained from Traditional Chinese Medicines Integrated Database (TCMID). Target genes of aloperine against CVD were collected from SwissTargetPrediction, DrugBank database, and Online Mendelian Inheritance in Man (OMIM) database. Gene Ontology (GO) enrichment analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway performance, and network construction were adopted to explore common target genes. Results. Our findings showed that 25 candidate targets were the interacting genes between aloperine and CVD. GO analysis revealed biological process, cellular component, and molecular function of these target genes. More importantly, the majority of enrichment pathways was found to be highly associated with the nitrogen metabolism by KEGG analysis. Core genes particularly in nitrogen metabolism pathway including carbonic anhydrase (CA) III, CA IV, CA VA, CA VB, CA VI, CA VII, CA IX, CA XII, and CA XIV can be modulated by aloperine in the nitrogen metabolism. Conclusion. Our work revealed the pharmacological and molecular mechanisms of aloperine against CVD and provided a feasible tool to identify the pharmacological mechanisms of single active ingredient of traditional Chinese medicines.Keywords
Funding Information
- Natural Science Foundation of Zhejiang Province (LQ20H020011)
This publication has 38 references indexed in Scilit:
- Biological Network Exploration with Cytoscape 3Current Protocols in Bioinformatics, 2014
- New Insights into Carbonic Anhydrase Inhibition, Vasodilation, and Treatment of Hypertensive-Related DiseasesCurrent Hypertension Reports, 2014
- Quantification of carbonic anhydrase gene expression in ventricle of hypertrophic and failing human heartBMC Cardiovascular Disorders, 2013
- TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysisNucleic Acids Research, 2012
- Binding of carbonic anhydrase IX to extracellular loop 4 of the NBCe1 Na+/HCO3− cotransporter enhances NBCe1-mediated HCO3− influx in the rat heartAmerican Journal of Physiology-Cell Physiology, 2012
- Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposureEuropean Heart Journal, 2012
- Carbonic anhydrase XIV in the normal and hypertrophic myocardiumJournal of Molecular and Cellular Cardiology, 2012
- Network pharmacologyNature Biotechnology, 2007
- Expression of Membrane-bound Carbonic Anhydrases IV, IX, and XIV in the Mouse HeartJournal of Histochemistry & Cytochemistry, 2006
- Laboratory and clinical observations on ethoxzolamide (Cardrase) as a diuretic agentThe American Journal of Cardiology, 1958